Rowad Tourism Company (EGX:ROTO)
Egypt · Delayed Price · Currency is EGP 25.53
-0.11 (-0.43%)
At close: Aug 6, 2025
CTI BioPharma Cash Flow Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | -21.11 | -19.74 | -9.43 | -42.14 | 5.54 | -14.22 | Upgrade |
Depreciation & Amortization | 17.99 | 14.3 | 7.1 | 1.26 | 0.4 | 0.58 | Upgrade |
Loss (Gain) From Sale of Assets | -27 | -31.99 | -0.46 | - | -0.66 | -0 | Upgrade |
Asset Writedown & Restructuring Costs | 1.27 | 1.27 | 1.27 | - | -0.3 | - | Upgrade |
Loss (Gain) From Sale of Investments | - | - | - | -0.92 | -15.32 | -0.19 | Upgrade |
Other Operating Activities | 18.73 | 17.62 | -3.69 | -3.37 | -2.49 | 0.93 | Upgrade |
Change in Other Net Operating Assets | 61.46 | 61.08 | 306.3 | 38.42 | 3.97 | -7.52 | Upgrade |
Operating Cash Flow | 51.33 | 42.54 | 301.09 | -6.74 | -8.85 | -20.42 | Upgrade |
Operating Cash Flow Growth | 275.18% | -85.87% | - | - | - | - | Upgrade |
Capital Expenditures | -286.69 | -287.18 | -323.67 | -31.43 | -57.91 | -135.67 | Upgrade |
Sale of Property, Plant & Equipment | 27 | 32 | 0.46 | - | 7.41 | 0 | Upgrade |
Investment in Securities | - | - | - | 19.87 | -5.98 | 105.96 | Upgrade |
Other Investing Activities | 219.23 | 219.43 | -2.2 | 14 | 28.19 | - | Upgrade |
Investing Cash Flow | -40.46 | -35.76 | -325.41 | 2.44 | -28.29 | -29.71 | Upgrade |
Short-Term Debt Issued | - | 0.07 | - | - | 39.91 | - | Upgrade |
Long-Term Debt Issued | - | - | 15.11 | 7.58 | 39.07 | 36.99 | Upgrade |
Total Debt Issued | -2.15 | 0.07 | 15.11 | 7.58 | 78.99 | 36.99 | Upgrade |
Short-Term Debt Repaid | - | - | -0 | -39.91 | - | - | Upgrade |
Long-Term Debt Repaid | - | -5.02 | - | - | - | - | Upgrade |
Total Debt Repaid | -8.03 | -5.02 | -0 | -39.91 | - | - | Upgrade |
Net Debt Issued (Repaid) | -10.18 | -4.95 | 15.11 | -32.34 | 78.99 | 36.99 | Upgrade |
Issuance of Common Stock | - | - | 9.65 | - | - | - | Upgrade |
Repurchase of Common Stock | - | - | - | -7.7 | - | - | Upgrade |
Common Dividends Paid | - | - | - | - | - | -29.08 | Upgrade |
Other Financing Activities | - | - | - | - | 3 | 10 | Upgrade |
Financing Cash Flow | -10.18 | -4.95 | 24.76 | -40.04 | 81.99 | 17.91 | Upgrade |
Miscellaneous Cash Flow Adjustments | 0 | 0 | -0 | - | - | - | Upgrade |
Net Cash Flow | 0.69 | 1.84 | 0.44 | -44.34 | 44.84 | -32.21 | Upgrade |
Free Cash Flow | -235.36 | -244.64 | -22.58 | -38.17 | -66.76 | -156.09 | Upgrade |
Free Cash Flow Margin | -157.93% | -222.22% | -49.40% | -292.67% | - | - | Upgrade |
Free Cash Flow Per Share | -13.60 | -14.13 | -1.30 | -2.21 | -3.86 | -9.02 | Upgrade |
Levered Free Cash Flow | -202.7 | -212.04 | -23.09 | -44.92 | -64.02 | -143.62 | Upgrade |
Unlevered Free Cash Flow | -202.16 | -211.43 | -22.03 | -42.61 | -64.02 | -143.62 | Upgrade |
Change in Net Working Capital | -65.17 | -66.06 | -301.32 | -3 | -5.51 | 4.18 | Upgrade |
Updated Dec 4, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.